Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers

American Journal of Surgery

Volumn 177, Issue 3, 1999, Pages 203-208

  Tabata, Tomoyuki ^a   Hazama, Shoichi ^a   Yoshino, Shigefumi ^a   Oka, Masaaki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DIGESTIVE SYSTEM CANCER; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CD4 LYMPHOCYTE COUNT; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKINS; INTRACELLULAR FLUID; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TH2 CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032949372     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00004-5     Document Type: Article

References (26)

1. Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348-2357.
2. Bloom B.R., Modlin R.L., Salgame P. Stigma variations observations on suppressor T cells and leprosy . Annu Rev Immunol. 10:1992;453-488.
3. Bloom B.R., Salgame P., Diamond B. Revisiting and revising suppressor T cells. Immunol Today. 13:1992;131-136.
4. Cher D.J., Mosmann T.R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol. 138:1987;3688-3694.
5. Stevens T.L., Bossie A., Sanders V.M., et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334:1988;255-258.
6. Mosmann T.R., Coffman R.L. TH1 and TH2 cells different patterns of lymphokine secretion lead to different functional properties . Ann Rev Immunol. 7:1989;145-173.
7. Romagnani S., Parronchi P., D'Elios M.M., et al. An update on human Th1 and Th2 cells. Int Arch Allergy Immunol. 113:1997;153-156.
8. Maeda H., Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol. 156:1996;73-78.
9. Maeda H., Kuwahara H., Ichimura Y., et al. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol. 155:1995;4926-4932.
10. Yamamoto N., Zou J.P., Li X.F., et al. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state. J Immunol. 154:1995;2281-2290.
11. Li X.F., Takiuchi H., Zou J.P., et al. Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function . Jpn J Cancer Res. 84:1993;315-325.
12. Zou J.P., Shimizu J., Ikegame K., et al. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. J Immunol. 148:1992;648-655.
13. Lee K.Y., Goedegebuure P.S., Linehan D.C., Eberlein T.J. Immunoregulatory effects of CD4+ T helper subsets in human melanoma. Surgery. 117:1995;365-372.
14. Pellegrini P., Berghella A.M., Del Beato T., et al. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother. 42:1996;1-8.
15. Schauer U., Jung T., Krug N., Frew A. Measurement of intracellular cytokines. Immunol Today. 17:1996;305-306.
16. Openshaw P., Murphy E.E., Hosken N.A., et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med. 182:1995;1357-1367.
17. Harmanek P., Sobin L.H. International Union Against Cancer TNM Classification of Malignant Tumours . 4th ed. 1992;Springer-Verlag, Berlin.
18. WHO Handbook for Reporting Results of Cancer Treatment. 1979;World Health Organization, Geneva.
19. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassay, and monoclonal antibody. J Exp Med. 166:1987;1229-1244.
20. Del Prete G.F., De Carli M., Mastromauro C., et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 88:1991;346-350.
21. Mosmann T.R., Sad S. The expanding universe of T-cell subsets Th1, Th2 and more . Immunol Today. 17:1996;138-146.
22. Dillman R.O., Koziol J.A., Zavanelli M.I., et al. Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer. 53:1984;1484-1491.
23. Hersh E.M., Patt Y.Z., Murphy S.G., et al. Radiosensitive, thymic hormone sensitive peripheral blood suppressor cell activity in cancer patients. Cancer Res. 40:1980;3134-3140.
24. Oka M., Mitsunaga H., Hazama S., et al. Natural killer activity and serum immunosuppressive protein levels in esophageal and gastric cancers. Surg Today. 23:1993;669-674.
25. Ferry B., Antrobus P., Huzicka I., et al. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin Exp Immunol. 110:1997;410-417.
26. Chalmers I.M., Janossy G., Contreras M., Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 92:1998;11-18.